Filter
5486
Filtered Results: 5486
Text search:
M.
Cheng
Featured
Recommendations
444
New Publications
1237
Language
Document type
No document type
2955
Studies & Reports
1164
Guidelines
687
Manuals
295
Strategic & Response Plan
148
Training Material
106
Fact sheets
88
Situation Updates
19
Resource Platforms
10
Infographics
9
Brochures
3
Online Courses
1
Videos
1
Countries / Regions
India
243
Global
226
Kenya
145
South Africa
121
Western and Central Europe
112
Nepal
100
Ethiopia
94
Malawi
83
Uganda
82
Nigeria
81
Sierra Leone
78
Latin America and the Carribbean
75
Tanzania
75
Africa
71
Bangladesh
67
Liberia
65
Rwanda
61
Zambia
60
Myanmar / Burma
58
Ghana
52
Congo, Democratic Republic of
50
Ukraine
49
Eastern Europe
49
Russia
45
Syria
43
Zimbabwe
40
Philippines
38
Brazil
38
Senegal
37
Germany
36
Burkina Faso
35
Lesotho
32
Guinea
29
West and Central Africa
29
South–East Asia Region
29
Asia
28
Cambodia
27
Middle East and North Africa
27
Cameroon
26
Indonesia
25
Mozambique
24
Namibia
24
Haiti
23
East and Southern Africa
22
South Sudan
22
Eastern Europe and Central Asia
21
Botswana
19
Benin
18
Colombia
15
Yemen
15
Madagascar
14
Eswatini/ Swaziland
14
Thailand
13
Chile
13
Venezuela
13
Argentina
13
Central African Republic
12
Afghanistan
11
USA
11
Pakistan
11
Tajikistan
10
China
10
Vietnam
10
Sudan
10
Ecuador
10
Spain
9
Western Pacific Region
8
Lebanon
8
Mali
8
Albania
7
Jordan
7
Paraguay
7
Sri Lanka
7
Laos
6
Kyrgyzstan
6
Peru
6
Côte d’Ivoire / Ivory Coast
6
Georgia
6
Iraq
6
Somalia
6
Turkey
5
Niger
5
Burundi
5
North America
5
France
5
Southern Africa
5
Moldova
5
United Kingdom
4
Portugal
4
Bolivia
4
Angola
4
North Macedonia
3
Mexico
3
Kazakhstan
3
Canada
3
Guinea-Bissau
3
Hungary
3
Japan
3
Poland
3
Guatemala
3
Timor Leste/ East Timor
2
Congo-Brazzaville
2
Malaysia
2
Morocco
2
Italy
2
Armenia
2
Croatia
2
Saudi Arabia
2
Jamaica
2
Papua New Guinea
2
Switzerland
1
El Salvador
1
Gambia
1
Togo
1
Iran
1
Fiji
1
Singapore
1
Estonia
1
Austria
1
Mongolia
1
Qatar
1
Lithuania
1
Gabon
1
Turkmenistan
1
Denmark
1
Tunisia
1
Norway
1
Israel
1
Latvia
1
Nicaragua
1
Egypt
1
Romania
1
Slovakia
1
Greece
1
Honduras
1
Chad
1
Libya
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1879
Clinical Guidelines
429
Public Health
303
Women & Child Health
285
Key Resources
236
Capacity Building
129
Pharmacy & Technologies
45
Toolboxes
Mental Health
523
COVID-19
475
HIV
399
Planetary Health
373
TB
271
Disability
210
Caregiver
178
AMR
142
NTDs
127
Global Health Education
122
NCDs
121
Rapid Response
112
Conflict
104
Ebola
102
Refugee
87
Pharmacy
76
Natural Hazards
64
Health Financing Toolbox
57
Social Ethics
38
Specific Hazards
33
Cholera
24
Zika
23
Polio
20
South Sudan
1
Health Financing
1
À l’ère des évolutions numérique, démocratique, sociétale et politique, la communication est devenue plus que jamais une passerelle d’idées et d’initiatives révolutionnaires, capable de créer des communautés plus fortes, plus informées et plus impliquées que jamais. L’émergence ...
Over 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan that causes Chagas disease
(CD). T. cruzi is transmitted by triatomine insects, congenitally, through uncontrolled blood donations and organ transplants,
and via consumption of food or drink contaminated by triatomi...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
Discrete typing units of Trypanosoma cruzi: Geographical and biological distribution in the Americas
Chagas disease caused by Trypanosoma cruzi is a public health issue in Latin America. This highly diverse parasite is divided into at least seven discrete typing units (DTUs) TcI-TcVI and Tcbat. Some DTUs have been associated with geographical distribution in epidemiological scenarios and clinical m...
Access to health workers who are fit for purpose, motivated and protected is a fundamental force of health service delivery and the achievement of universal health coverage and the health and health-related Sustainable Development Goals. Data and knowledge of the distribution, skill mix and future d...
These guidelines have been compiled for education ministries or other educational leaders (including development partners, non-governmental or private organizations working with schools or directly with caregivers) who want to adapt and adopt resources to support the marginalized caregivers of child...
These country profiles present progress on implementation of policy recommendations of the Global Action Plan on Physical Activity (GAPPA) 2018-2030 in each country. They also present an estimate of the cost to health systems of not taking action to improve physical activity levels and reinforce th...
Anopheles stephensi, a highly competent vector of Plasmodium falciparum and P. vivax, is considered an efficient vector of urban malaria. Until 2011, the reported distribution of An. stephensi was confined to certain countries of South Asia and parts of the Arabian Peninsula. Since then, the vector ...
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt...
Human schistosomiasis, a parasitic and often chronic illness, is one of the major neglected tropical diseases worldwide. It is estimated that 240 million people suffer from schistosomiasis, with more than 200000 fatalities recorded each year. Schistosomiasis is caused by an infection of the blood fl...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
In support of the London Declaration goals, PATH aims to catalyze engagement of the diagnostics industry and product development efforts. As part of this work, PATH conducted a diagnostic landscape analysis to identify gaps and evaluated current and nascent HAT diagnostics that may provide solutions...
Cholera which disproportionally impacts poor countries and the most vulnerable continues to affect at least 47 countries across the globe, resulting in an estimated 1.3 – 4 million cases, and 21,000 - 143,000 deaths per year worldwide. In Ethiopia, despite major improvements seen in the increasing...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field trial of a refined vector control tec...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
